Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac Amyloidosis

Authors

Institutions

Publication Details

Journal
Reviews in Cardiovascular Medicine
Published
2025-03-20
DOI
https://doi.org/10.31083/rcm26081
Citations
1
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac Amyloidosis

Christoph Krall, Nikita Ermolaev, Roza Badr Eslam, Robin Willixhofer et al.
1 citations
Reviews in Cardiovascular Medicine
Amyloidosis: Diagnosis, Treatment, Outcomes
0.81
article

Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac Amyloidosis

Christoph Krall, Nikita Ermolaev, Roza Badr Eslam, Robin Willixhofer, Andreas Kammerlander, Johannes Kästner, Franz Duca, Mahshid Eslami, Luciana Camuz Ligios, Michael Poledniczek, Jutta K Bergler-Klein, Christina Kronberger, René Rettl, Bernhard Gregshammer, Diana Ahmadi-Fazel, Christian Nitsche, Christina Binder
article en
1 citations

Abstract

No abstract available for this paper.
Reviews in Cardiovascular MedicineVol. 26(3)
Medical University of Vienna (AT)
Openalex Percentile: Top 30%
Amyloidosis: Diagnosis, Treatment, Outcomes
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.